Dr. Spigel Discusses PD-L1 Antibody for Non-Small Cell Lung Cancer Patients - Sarah Cannon Sarah Cannon Research Institute 1:34 8 years ago 61 Скачать Далее
Dr. David Spigel Discusses Diagnosis, Treatments, and Scientific Advances For Lung - HLN Sarah Cannon Research Institute 4:34 3 years ago 2 459 Скачать Далее
Lung Cancer Research Program - Sarah Cannon Sarah Cannon Research Institute 0:35 9 years ago 252 Скачать Далее
Dr. Spigel on Checkmate 017- Phase III Trial for Nivolumab - Sarah Cannon Sarah Cannon Research Institute 2:29 8 years ago 160 Скачать Далее
Understanding Immunotherapy and Its Potential - Sarah Cannon Sarah Cannon Research Institute 2:48 8 years ago 105 Скачать Далее
Dr. David Spigel Discusses the Evolving Non-Small Cell Lung Cancer Treatment Landscape OncLive 1:14 11 years ago 273 Скачать Далее
Dr. Spigel Discusses the Development of Onartuzumab for the Treatment of Lung Cancer OncLive 2:37 9 years ago 164 Скачать Далее
Dr. Melissa Johnson on Fox & Friends Discussing Immunotherapy in Lung Cancer - Sarah Cannon Sarah Cannon Research Institute 3:18 9 years ago 1 218 Скачать Далее
Dr. David Spigel Shares 2021 Cancer Research Updates - NBCLX Sarah Cannon Research Institute 5:55 2 years ago 411 Скачать Далее
Dr. David Spigel Discusses Risk Factors, Screening, and Breakthroughs For Lung Cancer - HLN Sarah Cannon Research Institute 4:42 3 years ago 769 Скачать Далее
Melissa Johnson, MD, on lung cancer patients that have a PD-L1 expression that is less than 1% OBRoncology 0:44 6 years ago 23 Скачать Далее
Dr. Gubens Discusses the Role of PD-L1 in Patients With NSCLC OncLive 1:02 5 years ago 248 Скачать Далее
Dr. Hirsch on Value of PD-L1 Testing in Patients With Lung Cancer OncLive 1:55 7 years ago 206 Скачать Далее
How does PD-L1 impact treatment options for lung cancer? American Lung Association 1:20 3 years ago 12 213 Скачать Далее
